Hepatitis C genotype 1: phase III Program of an all-oral Interferon-free therapyAbbVie has announced the completion of its phase III clinical program and released results of four additional studies designed to assess investigational all-oral, interferon-free therapy with and with ...
Novità nella terapia dell'epatite C: trattamento senza Interferone
Hepatitis C genotype 1: phase III Program of an all-oral Interferon-free therapyAbbVie has announced the completion of its phase III clinical program and released results of four additional studies designed to assess investigational all-oral, interferon-free therapy with and with ...